Down-regulation of artery in moderately differentiated hepatocellular carcinoma related to tumor development.

[1]  Masatoshi Kudo,et al.  Multistep human hepatocarcinogenesis: correlation of imaging with pathology , 2009, Journal of Gastroenterology.

[2]  T. Nagayasu,et al.  Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma. , 2008, World journal of gastroenterology.

[3]  H. Honda,et al.  Poorly Versus Moderately Differentiated Hepatocellular Carcinoma: Vascularity Assessment by Computed Tomographic Hepatic Angiography in Correlation With Histologically Counted Number of Unpaired Arteries , 2007, Journal of computer assisted tomography.

[4]  Y. Takeda,et al.  Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin‐2 and hypoxia‐induced factor‐1a , 2006, Liver international : official journal of the International Association for the Study of the Liver.

[5]  Josepa Ribes,et al.  Primary liver cancer: worldwide incidence and trends. , 2004, Gastroenterology.

[6]  E. Taniguchi,et al.  Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma. , 2004, Journal of hepatology.

[7]  M. Tsuneyoshi,et al.  Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma , 2003, Journal of clinical pathology.

[8]  M. Miyazaki,et al.  Angiopoietins and Tie‐2 expression in angiogenesis and proliferation of human hepatocellular carcinoma , 2003, Hepatology.

[9]  M. Feitelson,et al.  Genetic mechanisms of hepatocarcinogenesis , 2002, Oncogene.

[10]  H. Honda,et al.  Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. , 2002, AJR. American journal of roentgenology.

[11]  S. Ishiguro,et al.  Expression of smooth muscle calponin in tumor vessels of human hepatocellular carcinoma and its possible association with prognosis , 2002, Cancer.

[12]  K. Batts,et al.  Prognostic Histologic Indicators of Curatively Resected Hepatocellular Carcinomas: A Multi-institutional Analysis of 425 Patients With Definition of a Histologic Prognostic Index , 2002, The American journal of surgical pathology.

[13]  V. Yajnik,et al.  Pathology and genetics of tumors of the digestive system , 2001 .

[14]  Stanley J. Wiegand,et al.  Vascular-specific growth factors and blood vessel formation , 2000, Nature.

[15]  G. Yancopoulos,et al.  New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF , 1999, Oncogene.

[16]  A. Kovatich,et al.  Calponin and h-caldesmon in soft tissue tumors: consistent h-caldesmon immunoreactivity in gastrointestinal stromal tumors indicates traits of smooth muscle differentiation. , 1999, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[17]  Zeng-chen Ma,et al.  Microvessel density of hepatocellular carcinoma: its relationship with prognosis , 1999, Journal of Cancer Research and Clinical Oncology.

[18]  O. Matsui,et al.  Correlation between the blood supply and grade of malignancy of hepatocellular nodules associated with liver cirrhosis: evaluation by CT during intraarterial injection of contrast medium. , 1999, AJR. American journal of roentgenology.

[19]  M. Kojiro,et al.  Expression of vascular endothelial growth factor in human hepatocellular carcinoma , 1998, Hepatology.

[20]  T. Nabika,et al.  Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver , 1998, Hepatology.

[21]  T. Mitsui,et al.  Quantitation of sinusoid‐like vessels in hepatocellular carcinoma: Its clinical and prognostic significance , 1997, Hepatology.

[22]  K. Okuda.  Hepatocellular carcinoma: Clinicopathological aspects , 1997, Journal of gastroenterology and hepatology.

[23]  Thomas N. Sato,et al.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. , 1997, Science.

[24]  P. Bhathal,et al.  Endothelin‐induced vasoconstriction in isolated perfused liver preparations from normal and cirrhotic rats , 1997, Journal of gastroenterology and hepatology.

[25]  Pamela F. Jones,et al.  Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis , 1996, Cell.

[26]  G. Owens,et al.  Regulation of differentiation of vascular smooth muscle cells. , 1995, Physiological reviews.

[27]  K. Tanikawa,et al.  Predictive factors for long term prognosis after partial hepatectomy for patients with hepatocellular carcinoma in Japan. The liver cancer study group of japan , 1994, Cancer.

[28]  V. Koteliansky,et al.  Phenotypic changes of human smooth muscle cells during development: late expression of heavy caldesmon and calponin. , 1992, Developmental biology.

[29]  T. Terada,et al.  Vascular supply in adenomatous hyperplasia of the liver and hepatocellular carcinoma: a morphometric study. , 1992, Human pathology.

[30]  J. Folkman,et al.  Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. , 1991, The New England journal of medicine.

[31]  H. Honda,et al.  Arterial blood supply of hepatocellular carcinoma and histologic grading: radiologic-pathologic correlation. , 2008, AJR. American journal of roentgenology.

[32]  森永 聡一郎.  Angiogenesis in Hepatocellular Carcinoma as Evaluated by Alpha Smooth Muscle Actin Immunohistochemistry , 2000 .

[33]  N. Ferrara.  Vascular endothelial growth factor: molecular and biological aspects. , 1999, Current topics in microbiology and immunology.